ArticleProgress in community health partnerships : research, education, and action2024
COVID-19's Impact on Community Resilience Practice: Lessons Learned from an Academic-Community-Government Partnership to Reduce HBV.
Article in Progress in community health partnerships : research, education, and action, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ripple Effects Mapping: Evaluating Multilevel Perspectives and Impacts of a Statewide Community-Academic Partnership Network on Covid-19 Health Disparities.Health expectations : an international journal of public participation in health care and health policy · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundEssential to the global elimination of viral hepatitis are insights and guidelines on how to coordinate and sustain community health efforts during times of public health crises. A community-based participatory research-driven academic-community-government (ACG) partnership was formed to improve the hepatitis B virus (HBV) screening and vaccination infrastructure for at-risk communities in the Washington-Baltimore metropolitan region.
objectivesWe describe the challenges and innovative adjustments made by the partnership to provide continued prevention modalities to reduce HBV during the earlier phases of the COVID-19 pandemic.
methodsKey informant interviews were conducted to assess program implementation facilitators and barriers.
resultsThree thematic categories about the pandemic's impact on the ACG partnership emerged: innovations in hepatitis screening, access and linkage to care, and collaborative leadership. Lessons learned included the need to identify gaps in care, foster a safe environment for patients and staff, and provide technical assistance to enhance health information technology and systems infrastructure.
conclusionsDespite COVID-19, partnership members remained agile and responsive to community needs. Sustaining an effective ACG partnership requires regular and transparent communication, as well as shared and equal decision-making opportunities.
Indexed as
Identifiers
39925281PMC12283077What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.